In your DNA. Someone knows a lot about you. It's Asa Ren! They've just raised $8.1M in early-stage funding, and they build D2C DNA tests to help you learn everything about yourself — and so much more.

• They've already signed agreements with over 47 hospital and clinic partners to grow their distribution.

Investor check. Top Harvest Capital, Kejora Capital and Marcy Venture Partners co-led the round! Northstar Ventures, Naya Capital, Diagnos Laboratories and several angels also joined in!

‍

🧪 Testing, 1, 2, 3

Founded in 2016, they're one of Indonesia's first DNA data companies, and they're here to give you insight into yourself and your health.

But beyond just that, they're building the most diverse global clinical-genomic databases through their DNA tests and more.

For what?

• To speed up drug discovery, help personalize treatments for SEA's healthcare industry — and so much more through the power of genetic data.

‍

🧐 How it works

They have multiple tests like 360 DNA reports, ancestry tests, and tests for children!

• Get one of their tests delivered to your home, send the sample back and you'll receive the results in days.

360 DNA. It's the most complete test they have! Discover the changes you need to make in your diet, activities and lifestyle, as well as do's and don'ts and pre-disposed healthcare issues.

Asa Ancestry. Figure out who and where you came from — ethnic groups, geographical region and migration pattern across six continents and 200+ countries. Since Indonesia has 1,300+ ethnic groups, Asa Ren can pinpoint your exact origins as compared to typical DNA Ancestry tests from the west.

Asa Prodigy. Figure out your child's nutrition and health, personality, and fitness and how you can develop their learning and potential.

‍

😮 Not just a test

If you're buying one of their tests, you can also add on their services like health screenings and premium medical check-ups. Oh, and you can even access your DNA reports and data from their mobile app!

‍

💰 What's with the $$$?

They'll be doubling down on deepening their digital capabilities, developing clinical bioinformatics, an electronic health passport and a clinical-genomic database focused on non-communicable diseases.

• They also plan to add medical diagnosis and complete health data to their offerings.

‍